FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Price

Research Profile

Chemicals & Drugs

Concepts & Ideas

Procedures

Disorders

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Julia S Johansen; Stig E Bojesen; Anne Tybjaerg-Hansen; Anne K Mylin; Paul A Price; Børge G Nordestgaard
Plasma YKL-40 and total and disease-specific mortality in the general population.
Julia S Johansen; Stig E Bojesen; Anne K Mylin; Ruth Frikke-Schmidt; Paul A Price; Børge G Nordestgaard
Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population.
Anne Roslind; Ann S Knoop; Maj-Britt Jensen; Julia S Johansen; Dorte L Nielsen; Paul A Price; Eva Balslev
YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Price (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Julia S Johansen; Stig E Bojesen; Anne Tybjaerg-Hansen; Anne K Mylin; Paul A Price; Børge G Nordestgaard
Plasma YKL-40 and total and disease-specific mortality in the general population.
Clinical chemistry 2010;56(10):1580-91.
2009: Julia S Johansen; Stig E Bojesen; Anne K Mylin; Ruth Frikke-Schmidt; Paul A Price; Børge G Nordestgaard
Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):572-8.
2008: Anne Roslind; Ann S Knoop; Maj-Britt Jensen; Julia S Johansen; Dorte L Nielsen; Paul A Price; Eva Balslev
YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer.
Breast cancer research and treatment 2008;112(2):275-85.
2008: Anne Roslind; Julia S Johansen; Ib Jarle Christensen; Katalin Kiss; Eva Balslev; Dorte Lisbet Nielsen; Jens Bentzen; Paul A Price; Elo Andersen
High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.
International journal of cancer. Journal international du cancer 2008;122(4):857-63.
2007: Anne Roslind; Julia S Johansen; Nanna Junker; Dorte L Nielsen; Hanife Dzaferi; Paul A Price; Eva Balslev
YKL-40 expression in benign and malignant lesions of the breast: a methodologic study.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2007;15(4):371-81.
2007: Julia S Johansen; Klaus Brasso; Peter Iversen; Børge Teisner; Patrick Garnero; Paul A Price; Ib Jarle Christensen
Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3244-9.
2007: Merete Ringsholt; Estrid V S Høgdall; Julia S Johansen; Paul A Price; Lise H Christensen
YKL-40 protein expression in normal adult human tissues--an immunohistochemical study.
Journal of molecular histology 2007;38(1):33-43.
2007: Julia S Johansen; Benny Vittrup Jensen; Anne Roslind; Paul A Price
Is YKL-40 a new therapeutic target in cancer?
Expert opinion on therapeutic targets 2007;11(2):219-34.
2006: Klaus Brasso; Ib Jarle Christensen; Julia S Johansen; Børge Teisner; Patrick Garnero; Paul A Price; Peter Iversen
Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma.
The Prostate 2006;66(5):503-13.
2006: Julia S Johansen; Benny Vittrup Jensen; Anne Roslind; Dorte Nielsen; Paul A Price
Serum YKL-40, a new prognostic biomarker in cancer patients?
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(2):194-202.
2005: Jens Hjorth; Darach Watson; Johan P U Fynbo; Paul A Price; Brian L Jensen; Uffe G Jørgensen; Daniel Kubas; Javier Gorosabel; Páll Jakobsson; Jesper Sollerman; Kristian Pedersen; Chryssa Kouveliotou
The optical afterglow of the short gamma-ray burst GRB 050709.
Nature 2005;437(7060):859-61.
2005: Claudia Nordenbaek; Julia S Johansen; Poul Halberg; Allan Wiik; Charly Garbarsch; S Ullman; Paul A Price; Steffen Jacobsen
High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement.
Scandinavian journal of rheumatology 2005;34(4):293-7.
2005: Julia S Johansen; Nils Milman; Michael Hansen; Charly Garbarsch; Paul A Price; Niels Graudal
Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity?
Respiratory medicine 2005;99(4):396-402.
2003: Benny Vittrup Jensen; Julia S Johansen; Paul A Price
High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4423-34.
2003: Estrid V S Høgdall; Julia S Johansen; Susanne Krüger Kjaer; Paul A Price; Lise Christensen; Jan Blaakaer; Johannes E Bock; Eva Glud; Claus K Høgdall
High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival.
Oncology reports 2003;10(5):1535-8.
2003: Ida Vind; Julia S Johansen; Paul A Price; Pia Munkholm
Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease.
Scandinavian journal of gastroenterology 2003;38(6):599-605.
2003: Hannah Dehn; Estrid V S Høgdall; Julia S Johansen; Morten Jørgensen; Paul A Price; Svend A Engelholm; Claus K Høgdall
Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer.
Acta obstetricia et gynecologica Scandinavica 2003;82(3):287-93.
2002: Christina Cintin; Julia S Johansen; Ib Jarle Christensen; Paul A Price; Susanne Sørensen; Hans Jørgen Nielsen
High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.
Cancer 2002;95(2):267-74.
2002: Gitte Kronborg; Christian Ostergaard; Nina Weis; Henrik Nielsen; Niels Obel; Svend Stenvang Pedersen; Paul A Price; Julia S Johansen
Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease.
Scandinavian journal of infectious diseases 2002;34(5):323-6.
2001: B Volck; Julia S Johansen; Michael Stoltenberg; Charly Garbarsch; Paul A Price; Mikkel Ostergaard; K Ostergaard; Preben Løvgreen Nielsen; S Sonne-Holm; Ib Lorenzen
Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2001;9(3):203-14.
2001: Julia S Johansen; J R Kirwan; Paul A Price; M Sharif
Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction.
Scandinavian journal of rheumatology 2001;30(5):297-304.
2000: Estrid V S Høgdall; Julia S Johansen; Susanne Krüger Kjaer; Paul A Price; J Blaakjaer; Claus K Høgdall
Stability of YKL-40 concentration in blood samples.
Scandinavian journal of clinical and laboratory investigation 2000;60(4):247-51.
2000: Julia S Johansen; Per Christoffersen; Søren Møller; Paul A Price; Jens H Henriksen; Charly Garbarsch; Flemming Bendtsen
Serum YKL-40 is increased in patients with hepatic fibrosis.
Journal of hepatology 2000;32(6):911-20.
1999: Julia S Johansen; Bo Baslund; Charly Garbarsch; Michael Hansen; Michael Stoltenberg; Ib Lorenzen; Paul A Price
YKL-40 in giant cells and macrophages from patients with giant cell arteritis.
Arthritis and rheumatism 1999;42(12):2624-30.
1999: Julia S Johansen; Michael Stoltenberg; Michael Hansen; Adrian Florescu; Kim Hørslev-Petersen; Ib Lorenzen; Paul A Price
Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity.
Rheumatology (Oxford, England) 1999;38(7):618-26.
1999: Christina Cintin; Julia S Johansen; Ib Jarle Christensen; Paul A Price; Susanne Sørensen; Hans Jørgen Nielsen
Serum YKL-40 and colorectal cancer.
British journal of cancer 1999;79(9-10):1494-9.
1999: B Volck; K Ostergaard; Julia S Johansen; Charly Garbarsch; Paul A Price
The distribution of YKL-40 in osteoarthritic and normal human articular cartilage.
Scandinavian journal of rheumatology 1999;28(3):171-9.
1998: B Volck; Paul A Price; Julia S Johansen; Ole Sørensen; Thomas Benfield; Hans Jørgen Nielsen; J Calafat; Niels Borregaard
YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils.
Proceedings of the Association of American Physicians 1998;110(4):351-60.
1997: Julia S Johansen; Søren Møller; Paul A Price; Flemming Bendtsen; Jette Junge; Charly Garbarsch; Jens H Henriksen
Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis?
Scandinavian journal of gastroenterology 1997;32(6):582-90.